Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline’s legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol.
Subscribe for instant access to all Lawyerly content.